Monitor Telegram

Bringing about a higher level of transparency and accountability in provincial and federal governments to help protect taxpayers from abuse

Bringing about a higher level of transparency and accountability in provincial and federal governments to help protect taxpayers from abuse.

  • About the Monitor Telegram
    • Your Little Ol’ Canadian Goose Is Being Cooked
    • What Are These Guys Doing With Your Money?
    • Yes, Your Tax Dollars Are Being Blown Away!
    • My Old Age Pension Is How Much?
  • Tax Dollars Wasted
  • Government
  • Healthcare Waste
  • Nutty Stuff
  • International Waste
  • Contact Us

Canadian drug company under fire in U.K. after raising drug price 6,000%

November 22, 2017

Britain’s competition watchdog is accusing a Canadian drug company of making tens of millions of dollars by overcharging the British healthcare system and exploiting its patients.

Until this year, Concordia International was the U.K.’s only provider of liothyronine, a thyroid drug that’s primarily used to treat a condition caused by a deficiency of thyroid hormone. For British patients, such as Felicity Hart who had her thyroid removed in 2010, the tablets are literally a life-saver.

Read more at Global News

Filed Under: Healthcare Waste Tagged With: Canadian drug company, drug companies

Canada is long overdue for a national registry of drug company payments to doctors

October 17, 2017

Ontario recently took a historic step as the first province in Canada to introduce legislation that would shine a light on interactions between drug companies and prescribers. The use of the term “historic” here is not hyperbole, since the extent of payments by the pharmaceutical industry to individual physicians in Canada has never been known.

Other countries, such as the United States and France, have been making such information public for a few years now. But Ontario’s bill would provide a wider scope of transparency by including payments to prescribers of all sorts — not just doctors — into the mix, and even including payments from medical device companies.

Read more at Stat News

Filed Under: Healthcare Waste Tagged With: Canadian Health Care, drug companies

Potential changes concern pharma companies

October 2, 2017

Proposed changes to the way Canada puts a ceiling on patented drug prices have put pharmaceutical companies on alert, says an Ottawa intellectual property lawyer.

Earlier this summer, Health Canada released a consultation report entitled “Protecting Canadians from Excessive Drug Prices” that included a number of suggested amendments to the federal Patented Medicines Regulations, which are in turn used by the Patented Medicines Prices Review Board to determine the level at which a drug’s price crosses the threshold to become excessive.

Read more at Law Times News

Filed Under: Healthcare Waste Tagged With: big pharma, Canadian Health Care, drug companies, Federal Patented Medicines Regulations

Drug Giant Faced a Reckoning as China Took Aim at Bribery

November 7, 2016

Peter Humphrey was in the bathroom of his Shanghai apartment when the police kicked the door off its hinges and knocked him to the ground. Nearly two dozen officers stormed his home. They confiscated files, laptops and hard drives related to his work as a corporate investigator.

Mr. Humphrey and his wife, Yu Yingzeng, were taking to Building 803, a notoriously bleak criminal investigation center normally reserved for human smugglers, drug traffickers, and political activists. Sleep- deprived and hungry, he was transferred later that day to a detention house, placed in a cage and strapped to an iron chair. Outside, three officers sat on a podium and demanded answers.

Mr. Humphrey knew the reason for the harsh interrogation. He and Ms. Yu had been working for GlaxoSmithKline, the British pharmaceutical maker under investigation in China for fraud and bribery.

Source: http://www.nytimes.com/2016/11/02/business/international/china-rules-glaxo-bribes-sex-tape-whistleblower-cautionary-tale.html

Filed Under: International Tagged With: bribery, drug companies, fraud, investigation, scrutiny

Search This Site

Sign Up to receive our bi-weekly email newsletter!

  • This field is for validation purposes and should be left unchanged.

Publisher’s Views by Robert D. Smith

“Canada’s Taxpayer-Funded Medical Liability Protection Agency” – a Six-Part Series

April 17, 2018

The Monitor Telegram has been sent and been given permission to publish a … [Read More...]

Duplessis Orphans – Victims of Abuse in Quebec Suing Catholic Church and Quebec Government

February 8, 2018

Late last month, a motion to receive approval for a multi-million dollar … [Read More...]

Victim’s Descendent Finally Gets Meagre $100,000 from Canada for Montreal CIA Torture Experiments

November 30, 2017

One of the darkest chapters of Canadian history surely has to be the … [Read More...]

More Articles from Robert D. Smith

Contributors to the Monitor Telegram

Life Loans — Enabling Seniors to Live Better Lives

April 5, 2018 By editor

Executive Summary  Making loans to life insurance policyholders or the … [Read More...]

Legislation aimed at the root causes of Medicare and Medicaid fraud in the US

January 18, 2018 By Jeff, Leston

Recently the Health and Human Services Office of Inspector General issued a … [Read More...]

Reverse Mortgages and Life Settlements in Ontario in 2017

January 4, 2018 By Daniel Kahan

(This article has been written by Daniel Kahan ASA, with permission to … [Read More...]

More Contributor Articles

Copyright © 2025 · All Rights Reserved · Monitor Telegram · Read Our Privacy Policy